269 related articles for article (PubMed ID: 20141565)
1. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year.
Jorde R; Sneve M; Torjesen P; Figenschau Y
J Intern Med; 2010 May; 267(5):462-72. PubMed ID: 20141565
[TBL] [Abstract][Full Text] [Related]
2. Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults.
Scragg R; Khaw KT; Murphy S
Eur J Clin Nutr; 1995 Sep; 49(9):640-6. PubMed ID: 7498100
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men.
Nagpal J; Pande JN; Bhartia A
Diabet Med; 2009 Jan; 26(1):19-27. PubMed ID: 19125756
[TBL] [Abstract][Full Text] [Related]
4. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study.
Egert S; Bosy-Westphal A; Seiberl J; Kürbitz C; Settler U; Plachta-Danielzik S; Wagner AE; Frank J; Schrezenmeir J; Rimbach G; Wolffram S; Müller MJ
Br J Nutr; 2009 Oct; 102(7):1065-74. PubMed ID: 19402938
[TBL] [Abstract][Full Text] [Related]
5. Does vitamin D3 supplementation improve glucose homeostasis in overweight or obese women? A double-blind, randomized, placebo-controlled clinical trial.
Salehpour A; Shidfar F; Hosseinpanah F; Vafa M; Razaghi M; Amiri F
Diabet Med; 2013 Dec; 30(12):1477-81. PubMed ID: 23822797
[TBL] [Abstract][Full Text] [Related]
6. Effects of supplementation with multivitamin and mineral on blood pressure and C-reactive protein in obese Chinese women with increased cardiovascular disease risk.
Wang C; Li Y; Zhu K; Dong YM; Sun CH
Asia Pac J Clin Nutr; 2009; 18(1):121-30. PubMed ID: 19329405
[TBL] [Abstract][Full Text] [Related]
7. Effect of orlistat on cardiovascular disease risk in obese adults.
Swinburn BA; Carey D; Hills AP; Hooper M; Marks S; Proietto J; Strauss BJ; Sullivan D; Welborn TA; Caterson ID
Diabetes Obes Metab; 2005 May; 7(3):254-62. PubMed ID: 15811142
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D3 and the risk of CVD in overweight and obese women: a randomised controlled trial.
Salehpour A; Shidfar F; Hosseinpanah F; Vafa M; Razaghi M; Hoshiarrad A; Gohari M
Br J Nutr; 2012 Nov; 108(10):1866-73. PubMed ID: 22317756
[TBL] [Abstract][Full Text] [Related]
9. Treatment of vitamin D deficiency increases lower limb muscle strength in institutionalized older people independently of regular physical activity: a randomized double-blind controlled trial.
Moreira-Pfrimer LD; Pedrosa MA; Teixeira L; Lazaretti-Castro M
Ann Nutr Metab; 2009; 54(4):291-300. PubMed ID: 19729890
[TBL] [Abstract][Full Text] [Related]
10. Long-term effect of calcium-vitamin D(3) fortified milk on blood pressure and serum lipid concentrations in healthy older men.
Daly RM; Nowson CA
Eur J Clin Nutr; 2009 Aug; 63(8):993-1000. PubMed ID: 19156159
[TBL] [Abstract][Full Text] [Related]
11. Consumption of cod and weight loss in young overweight and obese adults on an energy reduced diet for 8-weeks.
Ramel A; Jonsdottir MT; Thorsdottir I
Nutr Metab Cardiovasc Dis; 2009 Dec; 19(10):690-6. PubMed ID: 19356912
[TBL] [Abstract][Full Text] [Related]
12. Increased vitamin D supplementation recommended during summer season in the gulf region: a counterintuitive seasonal effect in vitamin D levels in adult, overweight and obese Middle Eastern residents.
Al-Daghri NM; Al-Attas OS; Alokail MS; Alkharfy KM; El-Kholie E; Yousef M; Al-Othman A; Al-Saleh Y; Sabico S; Kumar S; Chrousos GP
Clin Endocrinol (Oxf); 2012 Mar; 76(3):346-50. PubMed ID: 21906116
[TBL] [Abstract][Full Text] [Related]
13. Effect of vitamin D3 supplementation on serum 25(OH)D, lipids and markers of insulin resistance in obese adolescents: a prospective, randomized, placebo-controlled pilot trial.
Nader NS; Aguirre Castaneda R; Wallace J; Singh R; Weaver A; Kumar S
Horm Res Paediatr; 2014; 82(2):107-12. PubMed ID: 25034315
[TBL] [Abstract][Full Text] [Related]
14. The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese.
Syvertsen C; Halse J; Høivik HO; Gaullier JM; Nurminiemi M; Kristiansen K; Einerhand A; O'Shea M; Gudmundsen O
Int J Obes (Lond); 2007 Jul; 31(7):1148-54. PubMed ID: 17031391
[TBL] [Abstract][Full Text] [Related]
15. Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia.
Dujovne CA; Zavoral JH; Rowe E; Mendel CM;
Am Heart J; 2001 Sep; 142(3):489-97. PubMed ID: 11526363
[TBL] [Abstract][Full Text] [Related]
16. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
[TBL] [Abstract][Full Text] [Related]
17. Sesame supplementation does not improve cardiovascular disease risk markers in overweight men and women.
Wu JH; Hodgson JM; Puddey IB; Belski R; Burke V; Croft KD
Nutr Metab Cardiovasc Dis; 2009 Dec; 19(11):774-80. PubMed ID: 19346113
[TBL] [Abstract][Full Text] [Related]
18. Effect of calcium supplementation on lipid profile in overweight or obese Iranian women: a double-blind randomized clinical trial.
Karandish M; Shockravi S; Jalali MT; Haghighizadeh MH
Eur J Clin Nutr; 2009 Feb; 63(2):268-72. PubMed ID: 17928806
[TBL] [Abstract][Full Text] [Related]
19. Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects.
Beilfuss J; Berg V; Sneve M; Jorde R; Kamycheva E
Cytokine; 2012 Dec; 60(3):870-4. PubMed ID: 22925537
[TBL] [Abstract][Full Text] [Related]
20. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.
Fontbonne A; Diouf I; Baccara-Dinet M; Eschwege E; Charles MA
Diabetes Metab; 2009 Nov; 35(5):385-91. PubMed ID: 19665415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
